Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
- 首页
Blog
最新的帖子
一月 21, 2021
West's Envision™ Verification System – Risk Mitigation for Quality of Drug Product
One factor of parenteral drug product quality is the container closure integrity (CCI) of the primary packaging system. The interaction between the sealing surface of the elastomeric component and the vial is vital to ensure stability of the drug product over the shelf life. Therefore, defects found on the elastomeric component can increase the risk of failure or end-of-the-line rejects.
Categories
Search the Blog
Archive
Load more
Loading...
以前的博客

八月 24, 2020
How to Include Elastomers in the Nitrosamine Risk Assessment

Dr. Bettine Boltres
Principal Scientific Affairs, Packaging & Delivery Systems

七月 24, 2019
Scientific Insight Enables Risk Mitigation: Why West is By our Customers’ Side

Fran DeGrazio
Vice President, Technical Services & Scientific Affairs